User preferences for a mobile application to report adverse events following vaccination

被引:4
|
作者
Nguyen, M. T. H. [1 ,2 ]
Ott, J. J. [1 ,3 ]
Caputo, M. [1 ]
Keller-Stanislawski, B. [4 ]
Klett-Tammen, C. J. [1 ,3 ]
Linnig, S. [5 ]
Mentzer, D. [4 ]
Krause, G. [1 ,3 ,5 ,6 ]
机构
[1] Helmholtz Ctr Infect Res, Dept Epidemiol, Inhoffenstr 7, D-38124 Braunschweig, Germany
[2] PhD Programme Epidemiol, Braunschweig, Germany
[3] Hannover Med Sch, Hannover, Germany
[4] Paul Ehrlich Inst, Langen, Germany
[5] PAPmed, Berlin, Germany
[6] TWINCORE, Inst Infect Dis Epidemiol, Hannover, Germany
来源
PHARMAZIE | 2020年 / 75卷 / 01期
关键词
APP; USABILITY;
D O I
10.1691/ph.2020.9734
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The passive surveillance system is an important tool in pharmacovigilance of vaccines. However, reporting of adverse events following immunization (AEFI) post-marketing has limitations regarding under-reporting, biased reports and lack of exposure data resulting in imprecise estimates. New mobile application technology may provide an opportunity for an enhanced surveillance. A pre-requisite for the use of new app-based technology is to identify practical challenges and end users' preferences for design of app-features. The objectives were (i) to investigate the recruitment and feasibility of an app-based study in Germany, (ii) to assess individuals' motivation to participate in such a study and (iii) to identify app-features for reporting AEFI. We conducted a cross-sectional study among employees of a financial institution who attended the occupational health office during the seasonal influenza vaccination in November 2017. Participants tested feasibility and assessed an app prototype for AEFI reporting by using a case vignette and a questionnaire. Of the 153 attending employees, 65 (42%) agreed to participate and returned the questionnaire. Twenty-three (63%) rated the experience of reporting AEFI with the app prototype to be positive. Among three features offered for gamification, collecting points was most frequently chosen (n=22, 34%). The main reason for declining participation was the apprehension about data protection (n=28, 43%). Results suggest that the app-based technology was well accepted and is a suitable supplement for AEFI reporting and in our study. A convincing data protection concept is likely to enhance acceptability of such a system.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 50 条
  • [1] Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System
    Jeon, Minji
    Kim, Jehun
    Oh, Chi Eun
    Lee, Jin-Young
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (17) : 1 - 8
  • [2] Adverse events following vaccination in premature infants
    Sen, S
    Cloete, Y
    Hassan, K
    Buss, P
    [J]. ACTA PAEDIATRICA, 2001, 90 (08) : 916 - 920
  • [3] Surveillance of Adverse Events Following HPV Vaccination
    Spila-Alegiani, S.
    Cliofi-degli-Atti, M.
    Da-Cas, R.
    Donati, S.
    Giambi, C.
    Massari, M.
    Raschetti, R.
    Salmaso, S.
    [J]. DRUG SAFETY, 2009, 32 (10) : 902 - 902
  • [4] Nursing practice in view of adverse events following vaccination
    Linheira Bisetto, Lucia Helena
    Cubas, Marcia Regina
    Malucelli, Andreia
    [J]. REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2011, 45 (05) : 1125 - 1131
  • [6] Ocular adverse events following vaccination: overview and update
    Cheng, John Yu
    Margo, Curtis E.
    [J]. SURVEY OF OPHTHALMOLOGY, 2022, 67 (02) : 293 - 306
  • [7] Retrospective Qualitative and Quantitative Analysis of Adverse Events following Vaccination
    Patel, Hardik
    Shah, Samidh
    Desai, Mira
    Kalaiselvan, V
    Singh, G. N.
    [J]. JOURNAL OF YOUNG PHARMACISTS, 2018, 10 (03) : 326 - 329
  • [8] Adverse Ocular Events following COVID-19 Vaccination
    Taher K. Eleiwa
    Eric D. Gaier
    Abid Haseeb
    Reem H. ElSheikh
    Ahmed B. Sallam
    Abdelrahman M. Elhusseiny
    [J]. Inflammation Research, 2021, 70 : 1005 - 1009
  • [9] DESIGN OF A MULTICENTER STUDY OF ADVERSE EVENTS FOLLOWING VACCINATION IN CHILDHOOD
    WASSILAK, SGF
    GLASSER, JW
    CHEN, RT
    BLACK, SB
    MULLOOLY, JP
    THOMPSON, RS
    [J]. STATISTICS IN MEDICINE, 1995, 14 (5-7) : 706 - 706
  • [10] Adverse Events Following Mass MenAfriVac™ Vaccination in Ghana, 2012
    Darko, D. Mimi
    Amponsa-Achiano, K.
    Sabblah, G.
    Antwi-Agyei, K. Odei
    Opuni, S. K.
    [J]. DRUG SAFETY, 2013, 36 (09) : 938 - 938